Literature DB >> 1686688

Control of Fasciola gigantica with triclabendazole in Indonesian cattle.

S Widjajanti, P Stevenson, I H Carmichael.   

Abstract

The efficacy of triclabendazole (TCBZ) against natural infections with Fasciola gigantica was evaluated in a field study using 102 Indonesian cattle. The animals were divided into two groups; one received TCBZ at 12 mg/kg orally every eight weeks for one year while the other remained untreated. Relative to controls the Fasciola faecal egg count in treated animals was significantly reduced (P less than 0.01) to almost zero at all observations. There were no differences between the groups in blood values and body mass gain. Plasma glutamate dehydrogenase (GLDH) levels in treated animals were reduced to within normal values, whereas those in controls remained above normal throughout. Although plasma gamma glutamyl transferase (GGT) levels remained within the normal range in both groups they were consistently higher in control than in treated animals. However, both GLDH and GGT levels in control animals were considerably lower than those reported by others in experimental low-level chronic fasciolosis, which suggests that only mild liver damage was caused by small numbers of F. gigantica in these animals. In addition to considerations of disease prevalence and economic data from abattoirs, control strategies for fasciolosis in Indonesian cattle require an evaluation of losses due to subclinical disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686688     DOI: 10.1007/bf02357103

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  4 in total

1.  Serum enzyme activity and bilirubin concentration in sheep experimentally infected with Fasciola gigantica.

Authors:  F el Samani; O M Mahmoud; M T Fawi; A A Gameel; E M Haroun
Journal:  J Comp Pathol       Date:  1985-10       Impact factor: 1.311

2.  Changes in plasma enzyme activities and other blood components in response to acute and chronic liver damage in cattle.

Authors:  P H Anderson; J G Matthews; S Berrett; P J Brush; D S Patterson
Journal:  Res Vet Sci       Date:  1981-07       Impact factor: 2.534

3.  Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.

Authors:  T M Craig; R L Huey
Journal:  Am J Vet Res       Date:  1984-08       Impact factor: 1.156

4.  Chronic subclinical ovine fascioliasis: plasma glutamate dehydrogenase, gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as diagnostic aids.

Authors:  A R Sykes; R L Coop; M G Robinson
Journal:  Res Vet Sci       Date:  1980-01       Impact factor: 2.534

  4 in total
  3 in total

1.  Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.

Authors:  Ana M Espino; Adelaida Morales; Bonnibel Delgado; Francheska M Rivera; Olgary Figueroa; Erick Suárez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

2.  Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.

Authors:  Daricel Torres; Ana M Espino
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.

Authors:  Ana M Espino; Daricel Torres; Adelaida Morales; Bonnibel Delgado; Julia Quetel; Antonio Osuna
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.